Moody's Rating for Glycorex Transplantation

MOODY'S ANALYTICS RISK SCORE

7

Moody’s Daily Credit Risk Score is a 1-10 score of a company’s credit risk, based on an analysis of the firm’s balance sheet and inputs from the stock market. The score provides a forward-looking, one-year measure of credit risk, allowing investors to make better decisions and streamline their work ow. Updated daily, it takes into account day-to-day movements in market value compared to a company’s liability structure.

Glycorex Transplantation AB is engaged in the research, development, production and sales in the field of organ transplantation. It focuses mainly in kidney transplant and also in liver, heart and pancreas, lung, and stem cell. Its product allows transplantation regardless of the blood types in donors and recipients. The company was founded by Kurt GÃ¶sta Ingemar Nilsson in 1996 and is headquartered in Lund, Sweden.